<--- Back to Details
First PageDocument Content
Antiemetics / Drug discovery / Pharmacology / Evaluation methods / 5-HT3 antagonist / Granisetron / Postoperative nausea and vomiting / Confidence interval / Clinical trial / Science / Statistics / Medicine
Antiemetics
Drug discovery
Pharmacology
Evaluation methods
5-HT3 antagonist
Granisetron
Postoperative nausea and vomiting
Confidence interval
Clinical trial
Science
Statistics
Medicine

20239S023 Granisetron Statistical PREA

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 38,19 KB

Share Document on Facebook

Similar Documents

Aquis Exchange Monthly Statistics Feb-2017 € 13,938,544,778 1,068,768,383  Value Traded

Aquis Exchange Monthly Statistics Feb-2017 € 13,938,544,778 1,068,768,383 Value Traded

DocID: 1xVY0 - View Document

Aquis Exchange Monthly Statistics Feb-2016 € 5,995,146,,183,444  Nestle SA

Aquis Exchange Monthly Statistics Feb-2016 € 5,995,146,,183,444 Nestle SA

DocID: 1xVWK - View Document

Aquis Exchange Monthly Statistics Feb-2018 € 17,012,038,916 1,321,056,240  Nestle SA

Aquis Exchange Monthly Statistics Feb-2018 € 17,012,038,916 1,321,056,240 Nestle SA

DocID: 1xVRB - View Document

Aquis Exchange Monthly Statistics May-2016 € 6,758,607,,245,455  Novartis AG

Aquis Exchange Monthly Statistics May-2016 € 6,758,607,,245,455 Novartis AG

DocID: 1xVO3 - View Document

Aquis Exchange Monthly Statistics Month: Value traded (EUR): Volume (no. of shares):  Jun-2017

Aquis Exchange Monthly Statistics Month: Value traded (EUR): Volume (no. of shares): Jun-2017

DocID: 1xVNh - View Document